LONDON – With Nevada, California and the UFC coming down hard on testosterone-replacement therapy, the futures of fighters who previously received permission to used the controversial treatment appear to be in jeopardy. That includes TRT user Vitor Belfort (24-10 MMA, 13-6 UFC), whose shot at the UFC middleweight title is on hold following his removal from a fight with champ Chris Weidman (11-0 MMA, 7-0 UFC) at UFC 173. Lyoto Machida (21-4 MMA, 13-4 UFC) is now slated to face the champ in the May 24 pay-per-view headliner. Belfort said he needs 90 days to adjust to fighting without doctor-prescribed testosterone and said he will meet the Weidman vs. Machida winner
See the rest here:
UFC’s Dana White ‘doesn’t care’ if TRT users aren’t able to fight again – MMA Junkie